Cargando…
Brusatol, an NRF2 inhibitor for future cancer therapeutic
BACKGROUND: Natural products from herbal medicines have long been investigated for their potentials as cancer therapeutics. Besides the development of several herbal medicine-derived anti-cancer agents, such as paclitaxel, vincristine and podophyllotoxin, many recent laboratory findings demonstrated...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554866/ https://www.ncbi.nlm.nih.gov/pubmed/31183074 http://dx.doi.org/10.1186/s13578-019-0309-8 |